
Gene therapy startup Lacerta Therapeutics raises $30M in equity financing from Sarepta
Sarepta Therapeutics gains rights to University of Florida-resident startup's programs for central nervous system diseases.
Sarepta Therapeutics gains rights to University of Florida-resident startup's programs for central nervous system diseases.